Company Filing History:
2 out of 5 
1 out of 1,974 
Years Active: 2023-2025
Title: Isaac Ciechanover: Innovator in Cancer Treatment
Introduction
Isaac Ciechanover is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of cancer treatment, particularly in ovarian cancer therapies. With a total of 2 patents, his work focuses on innovative methods to improve patient outcomes.
Latest Patents
Ciechanover's latest patents include methods for administering an anti-activin-A compound to treat ovarian cancer. The invention outlines a process that involves evaluating a subject's expression levels of specific biomarkers or angiogenic factors. In some embodiments, at least two compounds are administered, where the first is an anti-activin A compound and the second is a chemotherapeutic agent, such as capecitabine. This dual approach aims to enhance the effectiveness of treatment and identify suitable subjects for therapy.
Career Highlights
Throughout his career, Ciechanover has worked with prominent companies in the biotechnology sector, including Atara Biotherapeutics, Inc. and Amgen Inc. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.
Collaborations
Ciechanover has collaborated with notable colleagues, including Huiquan Han and Christopher Haqq. These partnerships have facilitated the advancement of his research and the development of his patented methods.
Conclusion
Isaac Ciechanover's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the field and offers hope for better therapeutic options in the future.